713 results on '"Roots I"'
Search Results
2. The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer
3. Genotype and Phenotype Relationship in Drug Metabolism
4. Designing a Simple Test to Measure and Rate Lubricant-Controlled Friction Reduction
5. Pharmakogenetik
6. Einschätzung eines phototoxischen Risikos bei Buchweizenkraut
7. Übersicht zu Interaktionsstudien mit Johanniskrautextrakten
8. Pharmakogenetik
9. Arzneimittelinteraktionen mit Johanniskrautextrakt
10. 4. Genetik-Workshop des Robert Koch-Instituts 2/99 in Berlin : Expertenveranstaltung vom 4. bis 6. Februar 1999 im Bundesinstitut für Arzneimittel und Medizinprodukte
11. Pharmakogenetik
12. Determination of Glutathione S-Transferase u Genotype in Humans by PCR-Amplified Gene-Probes
13. Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn’s disease
14. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication
15. A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment
16. Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19
17. Pharmakogenomik in der klinischen Praxis: Der Stellenwert pharmakogenetischer Tests in der antidepressiven Arzneitherapie
18. Bedeutung der Pharmakogenetik für die tägliche Praxis
19. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
20. Levosimendan: Klinische Indikationen einer neuen vasoaktiven Substanz
21. Interaktionen zwischen Phytopharmaka und anderen Arzneimitteln: Das BeispielJohanniskraut
22. Pharmakogenetik als Basis neuer Therapiekonzepte
23. Relationship between adverse effects of antipsychotic treatment and dopamine D2 receptor polymorphisms in patients with schizophrenia
24. The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels
25. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia
26. Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro
27. Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia
28. Genetic variants of the insulin receptor substrate-1 are influencing the therapeutic efficacy of oral antidiabetics
29. Relative Impact of Genotype and Enzyme Induction on the Metabolic Capacity of CYP2C9 in Healthy Volunteers
30. Untersuchung zur klinischen Relevanz der Acetyliererphänotypisierung bei 196 Urotheltumorpatienten
31. Acute myopathy in a type 2 diabetic patient on combination therapy with metformin, fenofibrate and rosiglitazone
32. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region
33. The kinetics of metamizol and its metabolites in critical-care patients with acute renal dysfunction
34. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients
35. V(26) BEDEUTUNG EINER HEREDITÄREN ADENIN-INSERTION IM ENDOTHELIN-1 GEN BEI PATIENTEN MIT EINEM SCHLAFAPNOE-SYNDROM
36. Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification
37. Polymorphisms of toxifying and detoxifying hepatic enzymes in amyotrophic lateral sclerosis
38. Quantitative determination of MDR1 mRNA expression in peripheral blood lymphocytes: a possible role of genetic polymorphisms in the MDR1 gene
39. Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+-ATPase inhibitors and other xenobiotics
40. Clearance of ceftriaxone in critical care patients with acute renal failure
41. Pharmacokinetic interaction between cyclosporin and diltiazem
42. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages
43. INTERACTION OF A HERBAL EXTRACT FROM ST. JOHN'S WORT WITH AMITRIPTYLINE AND ITS METABOLITES.
44. CYP2D6 AND CYP2C19 GENOTYPE BASED DOSE RECOMMENDATIONS IN ANTIDEPRESSANTS.
45. FREQUENCY OF CYP2D6 ALLELES AMONG 749 PATIENTS WITH SCHIZOPHRENIA.
46. CLINICAL RELEVANCE OF CYP2D6, 2C9 AND 2C19 POLYMORPHISMS FOR PERAZINE PHARMACOKINETICS.
47. Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the β2-adrenergic receptor among Turks
48. Single dose and steady state pharmacokinetics of temocapril and temocaprilat in young and elderly hypertensive patients
49. CONCORDANCE OF PHENOTYPE AND GENOTYPE FOR CYTOCHROME P450 2D6
50. A NOVEL CYP2C9 INTRON 2 T/C TRANSITION AND LINKAGE TO MUTATIONS LEU359 AND CYS144
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.